BioAtla, Inc.
BCAB- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001826892
No open-market purchases or sales by BioAtla, Inc. insiders were filed in the last 90 days; 21 institutions reported holding it in 13F filings for Q2 2026, worth $1.22M in total; no superinvestor holds it.
Q3 2023 vs. Q2 2023
How the institutions holding BioAtla, Inc. changed between Q2 2023 and Q3 2023.
All holders in Q3 2023All holders in Q2 2023
| Measure | Q2 2023 | Q3 2023 | Change |
|---|---|---|---|
| Holders | 87 | 82 | −5 |
| Shares | 32.0M | 30.1M | −1.91M (−6.0%) |
| Value | $96.1M | $51.3M | −$44.7M (−46.6%) |
New holders (7)
Institutions that held BioAtla, Inc. at the end of Q3 2023 but not at the end of Q2 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Panagora Asset Management Inc | 53,030 | $90.2K | 0.00% |
| Simplex Trading, LLC | 37,501 | $63.0K | 0.00% |
| SG Americas Securities, LLC | 21,963 | $37.0K | 0.00% |
| Belvedere Trading LLC | 9,668 | $16.4K | 0.00% |
| Allspring Global Investments Holdings, LLC | 3,169 | $5.39K | 0.00% |
| Federated Hermes, Inc. | 2,053 | $3.49K | 0.00% |
| Nisa Investment Advisors, LLC | 48 | $82 | 0.00% |
Sold out (12)
Institutions that held BioAtla, Inc. at the end of Q2 2023 and filed for Q3 2023 without it.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| Jane Street Group, LLC | 50,450 | $151.3K |
| Transcend Wealth Collective, LLC | 49,000 | $147.0K |
| Cubist Systematic Strategies, LLC | 44,476 | $133.4K |
| Man Group plc | 37,588 | $112.8K |
| Mirae Asset Global Investments Co., Ltd. | 26,899 | $80.7K |
| Rinkey Investments | 25,310 | $75.9K |
| MetLife Investment Management | 24,978 | $74.9K |
| Verition Fund Management LLC | 18,296 | $54.9K |
| State Board of Administration of Florida Retirement System | 12,560 | $37.7K |
| Denali Advisors LLC | 7,300 | $21.9K |
| Metropolitan Life Insurance Co | 2,588 | $7.76K |
| Impact Partnership Wealth, LLC | 129 | $387 |